Giorgia Sulis
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneArticle | Published in 2015 in European Respiratory JournalKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Edith Alarcon Arrascue, Jan Willem Alffenaar, Jose A. Caminero, Mina Gaga, Gina Gualano, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Valentina Alarcon Guizado, Saverio De Lorenzo, Aurora Jazmín Roby Arias, Anna Scardigli, Onno W. Akkerman, Alena Aleksa, Janina Artsukevich, Vera Auchynka, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Marie-Christine Payen, Andrea Piana, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workGiovanni Sotgiu2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy4Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy30These authors contributed equally to this workMarcos Abdo Arbex5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilEdith Alarcon Arrascue7International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceJan Willem Alffenaar9University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsJose A. Caminero8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, SpainMina Gaga11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAlena Skrahina13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic14National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiorgia Sulis15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini16Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyValentina Alarcon Guizado17National Tuberculosis Control Programme, Ministry of Health, Lima, PeruSaverio De Lorenzo18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyAurora Jazmín Roby Arias19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceOnno W. Akkerman20University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The NetherlandsAlena Aleksa21Educational Institution “Grodno State Medical University”, Grodno, BelarusJanina Artsukevich21Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Auchynka13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries22KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst23Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceMarie-Christine Payen24Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, BelgiumAndrea Piana2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- The Challenge of Tuberculosis in the 21st CenturyEdited by Alberto L. García-Basteiro, Füsun Öner Eyüboglu and Molebogeng X. RangakaBook | Published in 2023DOI: 10.1183/2312508X.erm10123ISBN (electronic): 978-1-84984-170-2Alberto L. García-BasteiroFüsun Öner Eyüboglu
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.